Sanofi reinforced its commitment to biotechnology innovation with a $625 million capital boost to Sanofi Ventures, expanding total assets over $1.4 billion. The venture fund aims to back early-stage startups with a focus on immunology, rare diseases, neurology, and vaccines, alongside digital health and AI-driven platforms. Separately, Rhythm Diagnostic Systems secured €14 million to advance its Multisense remote patient monitoring device. Mondego Bio launched with Series A funding, backed by major investors, to develop cancer immunotherapy candidates.